Characterization of Lesions of the Breast with Proton MR Spectroscopy: Comparison of Carcinomas, Benign Lesions, and Phyllodes Tumors

American Journal of Roentgenology

Volumn 181, Issue 5, 2003, Pages 1267-1272

  Tse, Gary M K ^a   Cheung, Humairah S ^a,b   Pang, Lai Man ^a   Chu, Winnie C W ^a   Law, Bonita K B ^a   Kung, Fred Y L ^a   Yeung, David K W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; KI 67 ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; BREAST FIBROADENOMA; BREAST HAMARTOMA; BREAST LESION; BREAST PAPILLOMA; CYSTOSARCOMA PHYLLOIDES; DIAGNOSTIC ACCURACY; FEMALE; FIBROCYSTIC BREAST DISEASE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; ONCOGENE NEU; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR VASCULARIZATION;

EID: 0142031597     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.181.5.1811267     Document Type: Article

References (33)

1. Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661-666
2. Cheng LL, Chang IW, Smith BL, Gonzalez RG. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 1998;135:194-202
3. 31P-NMR studies of cells and tumors. MAGMA 1998;6:44-52
4. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209:269-275
5. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1) H MR spectroscopy. J Magn Reson Imaging 1999;10:159-164
6. Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo (1) H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998;8:1191-1197
7. Sijens PE, Wijrdeman HK, Moerland MA, Bakker CJ, Vermeulen JW, Luyten PR. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology 1988;169:615-620
8. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast enhanced in vivo proton MR spectroscopy-initial results. Radiology 2001;220:40-46
9. Yeung DK, Yang WT, Tse GM. Human breast cancer: in vivo proton MR spectroscopy in the characterization of histopathological subtypes and preliminary observations in axillary node metastases. Radiology 2002;225:190-197
10. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68:45-54
11. Gribbestad IS, Bakken IJ, Singstad TE, Kvistad KA. Determination of choline content in breast tumors with H-1 MR spectroscopy: an external standard method. (abstr) In: [No editors listed]. Proceedings of the seventh meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, CA: International Society for Magnetic Resonance in Medicine, 1999:1587
12. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43
13. van den Boogaart A, van Hecke P, van Huffel S, Graveron-Demilly D, van Ormondt D, de Beer R. MRUI: a graphical user interface for accurate routine MRS data analysis. MAGMA 1996; 4[suppl 2]:318
14. van den Boogaart A, van Ormondt D, Pijnappel WWF, de Beer R, Ala-Korpela M. Removal of the water resonance from H-1 magnetic resonance spectra. In: McWhirter JG, ed. Mathematics in signal processing III. Oxford, England: Clarendon, 1994:175-195
15. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887
16. Gribbestad IS, Fjosne HE, Haugen OA, et al. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. Anticancer Res 1993;13:1973-1980
17. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 1994;7:181-194
18. Ting YT, Sherr D, Degani H. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 1996;16:1381-1388
19. Katz-Brull R, Margalit R, Degani H. Differential routing of choline in implanted breast cancer and normal organs. Magn Reson Med 2001;46:31-38
20. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipids metabolism of human mammary epithelial cells. Cancer Res 1999;59:80-84
21. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 2002;62:1966-1970
22. 31P measurements of response to treatment. NMR Biomed 1998;11:314-340
23. Smith TA, Eccles S, Ormerod MG, Tombs AJ, Titley JC, Leach MO. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br J Cancer 1991;64:821-826
24. Smith TA, Bush C, Jameson C, et al. Phospholipid metabolites, prognosis and proliferation in human breast carcinoma. NMR Biomed 1993;6:318-323
25. Barnard NJ, Hall PA, Lemoine NR, Kadar N. Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987;152:287-295
26. Midulla C, De Iorio P, Nagar C, et al. Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: correlation with lymph node status and other clinical pathologic parameters in breast cancer. Anticancer Res 1999;19:4033-4037
27. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994;144:1188-1194
28. Kato T, Kameoka S, Kimura T. et al. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 2001;70:65-74
29. Cotran RS, Kumar V, Collins T. Neoplasia. In: Cotran RS, Kumar V, Collins T, et al., eds. Robbins pathologic basis of disease, 6th ed. Philadelphia: Saunders. 1999:280-282
30. Rosen PP. Rosen's breast pathology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:176-197
31. Tse GM, Ma TK, Chan KF, et al. Increased microvessel density in malignant and borderline mammary phyllodes tumours. Histopathology 2001;38:67-70
32. Gatalica Z, Lucio E, Finkelstein S, Palazzo J, Tawlik O. The role of p53 mutation and Ki-67 proliferation index in the diagnosis and progression of phyllodes tumor of the breast. (abstr) Lab Invest 1999;79:21A
33. Tse GM, Putti TC, Kung FY, et al. Increased p53 protein expression in malignant mammary phyllodes tumors. Mod Pathol 2002;15:734-740